Last Updated : April 23, 2018
Details
Project Line:
New at CADTH
Final Biosimilar Summary Dossier Issued:
Drug Reimbursement Recommendations
CADTH Common Drug Review (CDR)
- Tocilizumab (Actemra): Giant cell arteritis (GCA)
- Tenofovir alafenamide (Vemlidy): Hepatitis B, chronic
CDR Update 135: Application Fees for CADTH Pharmaceutical Reviews — Adjustment
CADTH pan-Canadian Oncology Drug Review (pCODR)
- Pembrolizumab (Keytruda): Metastatic Urothelial Carcinoma
- Venetoclax (Venclexta): Chronic Lymphocytic Leukemia
- Brentuximab Vedotin (Adcetris): Hodgkin’s Lymphoma at high risk of relapse or progression post-ASCT
pCODR Update 66: New Resource for Patient Groups Will Help Enhance Submissions to CADTH’s pan-Canadian Oncology Drug Review
Cancer Drug Pipeline Information
The Cancer Drug Pipeline Information for Patient Groups is updated each month.
CADTH Resources
Read the latest “Evidence Matters” column in Hospital News: “Optimal strategies for the diagnosis of pulmonary embolism.”
April is Oral Health Month. See our Evidence Bundle on Oral and Dental Health.
Read “CADTH produces Canadian inventory of DI equipment” in Canadian Healthcare Technology.
In Brief:
- Optimal Strategies to Diagnose Acute Pulmonary Embolism
- Dialysis Modalities for the Treatment of End-Stage Kidney Disease
- Composite Resin Versus Amalgam for Dental Restorations
Resources to Address the Opioid Crisis
A new tool is available: Mind the Research Gaps — Treating Opioid Use Disorder. This tool highlights evidence requested for decision-making: what we found and what we did not find.
Rapid Response: Metadol Liquid, Methadose, and Compounded Methadone in Patients Using Opioid Agonist Therapy: Comparative Clinical Effectiveness and Guidelines
Environmental Scan: Policies to Reduce Harms from the Concomitant Use of Opioids and Central Nervous System Depressant Drugs
Health Technology Management Products
Rapid Response
Reports completed in March.
Recent Summaries of Evidence With Critical Appraisals Include:
- Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
- Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness
- Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: A Review of Clinical Effectiveness
- Fetal Scalp Lactate Testing During Intrapartum Pregnancy with Abnormal Fetal Heart Rate: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Health Technology Assessment
Issues in Emerging Health Technologies
- Issue 168 — A Noncultured Autologous Skin Cell Spray Graft for the Treatment of Burns
- Issue 169 — Voretigene Neparvovec: An Emerging Gene Therapy for the Treatment of Inherited Blindness
- Issue 170 — A Gene Expression Test to Assess the Likelihood of Obstructive Coronary Artery Disease
- Issue 171 — Gene Therapy: An Overview of Approved and Pipeline Technologies
Horizon Scan Roundup — 2017 — Part 2
Optimal Use
The Canadian Medical Imaging Inventory, 2017 was launched at the 2018 CADTH Symposium. The video recording will soon be available on our website.
Environmental Scan
News and Events
Don’t Miss Out! The Call for Nominations Deadline is April 27, 2018
CADTH is looking for multiple, new, qualified members to join our advisory and expert committees ― including patient, public, and expert members such as methodologists, clinicians, and economists. This is an exciting opportunity to become involved in the important contributions CADTH makes to the health care system. The deadline to submit a nomination closes Friday, April 27, 2018, at 4 p.m. EDT. Complete details can be found on our website at www.cadth.ca/nominations.
HTAi 2018 Vancouver
CADTH is pleased to be co-hosting the HTAi 2018 Annual Meeting in Vancouver from June 1 to 5, 2018. Register today!
Symposium
Our 2018 CADTH Symposium — Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care — was another great success and we thank everyone who was able to attend despite some weather-related challenges that affected travel! Held April 15 to 17 in Halifax, Nova Scotia, more than 650 delegates — academics, health care and government-decision-makers, health practitioners, patient and industry representatives, and CADTH staff — gathered to talk about health technology management. Dr. Brian O’Rourke and Dr. Maureen Trudeau were interviewed on CBC Information Morning Nova Scotia on April 17.
We were pleased to recognize Dr. Tony Fields and Dr. Michelle Mujoomdar for their contributions to the field of health technology assessment during our Recognition Awards Luncheon:
CADTH Recognizes “Rising Star” Dr. Michelle Mujoomdar
CADTH Honours Dr. Tony Fields, “Father” of Cancer-Related Health Technology Assessment in Canada
Articles about the 2018 CADTH Symposium:
CADTH — “Deputy Ministers Call Out Patient Engagement as Key to Transforming Health Care.”
CMAJ — “Opioids and pharmacare top of mind at annual CADTH meeting,” and “Low awareness about CADTH among practising doctors in Canada.”
Photos, Presentations, and Videos
You can also see photos from the event on the CADTH Flickr page. Don’t hesitate to share these with your networks! Looking for a presentation from one of our concurrent panel or oral sessions? Check out the Symposium website. And stay tuned for recordings of the three plenary live streams, the CMII launch, and the webinar on opioids.
Tell Us What You Think
We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.
CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.
Last Updated : April 23, 2018